As more and more judges ponder the merits of an off-patent drug with a purported ability to treat COVID-19, some health care lawyers are worried about a future where courts are ready to second-guess physicians whose patients don’t get what they want.

Courts across the country have been ordering hospitals to allow COVID-19 patients to undergo treatment with Ivermectin, overruling the hospital’s protests and arguments about standards of care that exclude the drug. They have issued orders mandating Ivermectin treatment, even though the Food and Drug Administration, the Centers for Disease Control and Prevention, the World Health Organization and the American Medical Association have warned against using it to treat COVID-19.

Big Personalities

James Beck of Reed Smith. Courtesy photo

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]